Cc1ccc2c(c1)[C@H]1OCC[C@H]1[C@@H](c1ccncc1)N2
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?